71703-26-9

Basic information

• Product Name: [2-(chloromethyl)phenyl]methyl acetate
• Synonyms: [2-(chloromethyl)phenyl]methyl acetate
• CAS NO: 71703-26-9
• Molecular Weight: 198.649
• Mol File: 71703-26-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: [2-(chloromethyl)phenyl]methyl acetate(CAS DataBase Reference)
• NIST Chemistry Reference: [2-(chloromethyl)phenyl]methyl acetate(71703-26-9)
• EPA Substance Registry System: [2-(chloromethyl)phenyl]methyl acetate(71703-26-9)

Safety Data

• Hazardous Substances Data: 71703-26-9(Hazardous Substances Data)

Upstream product

• 108-24-7 acetic anhydride 
• 142066-41-9 2-(chloromethyl)-phenyl methanol 
• 496-14-0 1,3-dihydroisobenzofuran 
• 75-36-5 acetyl chloride 
• 612-14-6 phthalyl alcohol 
• 612-12-4 o-Xylylene dichloride 

Downstream Products

• 1173021-41-4 2-[(diethoxyphosphoryl)methyl]benzyl acetate 
• 71703-32-7 2-(2-Hydroxymethyl-benzyl)-2,5,5-trimethyl-cyclohexane-1,3-dione 
• 71703-30-5 2-Benzyl-2-(2-hydroxymethyl-benzyl)-5,5-dimethyl-cyclohexane-1,3-dione 
• 71742-83-1 2-Allyl-2-(2-hydroxymethyl-benzyl)-5,5-dimethyl-cyclohexane-1,3-dione 
• 71703-34-9 Acetic acid 2-(1,4,4-trimethyl-2,6-dioxo-cyclohexylmethyl)-benzyl ester 

Relevant articles and documents

Syntheses of 5-chlorouracils/thymines with 1-[phosphono(methyl/ difluoromethyl)]-1,2-unsaturated-moiety-substituted methyl groups at N(1) and human thymidine phosphorylase inhibitory activity

By attaching (methyl)- or (difluoromethyl)-phosphonate groups to the 1-positions of ethene, cyclopentene or benzene, and attaching 1-(methyl)-5-chlorouracil or 1-(methyl)thymine groups to the corresponding 2-positions, compounds 1 - 5 were prepared as pot

Imidazopyridine compounds and processes for preparation thereof

The invention relates to an imidazopyridine compound of the formula: STR1 wherein R1 is lower alkynyl, lower alkynyloxy(lower)alkyl or N,N-di(lower)alkylamino(lower)alkynyl, R2 is lower alkyl, R3 is mono (or di or tri)-phenyl(lower)alkyl substituted by one or more substituent(s) selected from cyano, carbamoyl, mono (or di or tri(phenyl(lower)alkylamino, acylamino, carboxy, esterified carboxy, hydroxy, hydroxy(lower)alkyl, acyloxy(lower)alkyl, acyloxy, mono (or di or tri)phenyl(lower)alkoxy, lower alkoxy(lower)alkoxy, tetrahydropyranyloxy, and acylamino(lower)alkyl or mono (or di or tri) phenyl(lower)alkyl substituted by lower alkyl and one additional substituent selected from hydroxy(lower)alkyl, amino, N-lower alkyl-N-acylamino, mono (or di or tri)phenyl(lower)alkylamino, acylamino and lower alkylamino, and R4 is hydrogen or lower alkyl, and a pharmaceutically acceptable salt thereof, useful in the treatment of ulcers.